Ningbo David Medical Device Co., Ltd.

SZSE:300314 Stock Report

Market Cap: CN¥3.4b

Ningbo David Medical Device Past Earnings Performance

Past criteria checks 1/6

Ningbo David Medical Device has been growing earnings at an average annual rate of 8.4%, while the Medical Equipment industry saw earnings growing at 6.1% annually. Revenues have been growing at an average rate of 10.5% per year. Ningbo David Medical Device's return on equity is 7.5%, and it has net margins of 15.7%.

Key information

8.4%

Earnings growth rate

8.0%

EPS growth rate

Medical Equipment Industry Growth16.0%
Revenue growth rate10.5%
Return on equity7.5%
Net Margin15.7%
Last Earnings Update30 Sep 2024

Recent past performance updates

Ningbo David Medical Device's (SZSE:300314) Shareholders Have More To Worry About Than Only Soft Earnings

Oct 30
Ningbo David Medical Device's (SZSE:300314) Shareholders Have More To Worry About Than Only Soft Earnings

Weak Statutory Earnings May Not Tell The Whole Story For Ningbo David Medical Device (SZSE:300314)

Apr 26
Weak Statutory Earnings May Not Tell The Whole Story For Ningbo David Medical Device (SZSE:300314)

Recent updates

Ningbo David Medical Device's (SZSE:300314) Shareholders Have More To Worry About Than Only Soft Earnings

Oct 30
Ningbo David Medical Device's (SZSE:300314) Shareholders Have More To Worry About Than Only Soft Earnings

Earnings Tell The Story For Ningbo David Medical Device Co., Ltd. (SZSE:300314) As Its Stock Soars 28%

Sep 27
Earnings Tell The Story For Ningbo David Medical Device Co., Ltd. (SZSE:300314) As Its Stock Soars 28%

Even With A 27% Surge, Cautious Investors Are Not Rewarding Ningbo David Medical Device Co., Ltd.'s (SZSE:300314) Performance Completely

May 22
Even With A 27% Surge, Cautious Investors Are Not Rewarding Ningbo David Medical Device Co., Ltd.'s (SZSE:300314) Performance Completely

Weak Statutory Earnings May Not Tell The Whole Story For Ningbo David Medical Device (SZSE:300314)

Apr 26
Weak Statutory Earnings May Not Tell The Whole Story For Ningbo David Medical Device (SZSE:300314)

Ningbo David Medical Device Co., Ltd.'s (SZSE:300314) Shares Leap 31% Yet They're Still Not Telling The Full Story

Mar 06
Ningbo David Medical Device Co., Ltd.'s (SZSE:300314) Shares Leap 31% Yet They're Still Not Telling The Full Story

Revenue & Expenses Breakdown

How Ningbo David Medical Device makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

SZSE:300314 Revenue, expenses and earnings (CNY Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 245628816759
30 Jun 2456710216756
31 Mar 2461613617650
31 Dec 2361814817748
30 Sep 2361514418347
30 Jun 2361415318246
31 Mar 2356613816347
01 Jan 235069715646
30 Sep 224988916649
30 Jun 224814916646
31 Mar 224776816849
01 Jan 224748016750
30 Sep 214697715442
30 Jun 2148214614444
31 Mar 2147814413541
31 Dec 2046013612440
30 Sep 2043614811741
30 Jun 203989911040
31 Mar 20366679940
31 Dec 19356629640
30 Sep 19341328837
30 Jun 19310238035
31 Mar 19300248233
31 Dec 18300298028
30 Sep 18287347725
30 Jun 18290347227
31 Mar 18295427222
31 Dec 17304477418
30 Sep 17303657610
30 Jun 1729669810
31 Mar 1727964770
31 Dec 1626562750
30 Sep 1623757670
30 Jun 1622249680
31 Mar 1622146690
31 Dec 1521945680
30 Sep 1522553660
30 Jun 1522353640
31 Mar 1523055640
31 Dec 1422754630
30 Sep 1422754590
30 Jun 1421855570
31 Mar 1420957520
31 Dec 1321764530

Quality Earnings: 300314 has a high level of non-cash earnings.

Growing Profit Margin: 300314's current net profit margins (15.7%) are lower than last year (23.4%).


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 300314's earnings have grown by 8.4% per year over the past 5 years.

Accelerating Growth: 300314's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.

Earnings vs Industry: 300314 had negative earnings growth (-38.9%) over the past year, making it difficult to compare to the Medical Equipment industry average (-8.8%).


Return on Equity

High ROE: 300314's Return on Equity (7.5%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies